Ticker
LRMRCompany Name
LARIMAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -92.59M | -25.39% | $ 364.62M |
3/31/2025 | $ -87.45M | -51.54% | $ 169.67M |
12/31/2024 | $ -71.28M | -48.82% | $ 145.98M |
9/30/2024 | $ -58.79M | -10.89% | $ 539.8M |
6/30/2024 | $ -43.38M | -9.14% | $ 474.72M |
3/31/2024 | $ -36.48M | -7.28% | $ 501.48M |
12/31/2023 | $ -33.62M | -6.06% | $ 554.74M |
9/30/2023 | $ -30.79M | -27.39% | $ 112.4M |
6/30/2023 | $ -27.47M | -16.66% | $ 164.89M |
3/31/2023 | $ -27.69M | -17.82% | $ 155.34M |
FCF / Market Cap
(=) FCF Yield
FCF Yield for LARIMAR THERAPEUTICS INC is calculated as follows: FCF [ $ -42.5M ] / Market Cap [ $ 296.37M ]
(=) FCF Yield [ -14.34% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |